Is Prophylactic Therapy for Varices Justified? Can the First Variceal Bleed be Predicted?
Author(s) -
G W Johnston
Publication year - 1989
Publication title -
hpb surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.561
H-Index - 26
eISSN - 1607-8462
pISSN - 0894-8569
DOI - 10.1155/1989/68458
Subject(s) - medicine , bleed , varices , rescue therapy , general surgery , gastroenterology , surgery , cirrhosis
The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A Prospective Multicenter Study. The New England Journal of Medicine 319,983-989. We conducted a prospective study of 321 patients with cirrhosis of the liver and esophageal varices with no history ofbleeding to see whether a comprehensive analysis of their clinical features and of the endoscopic appearances of their varices could help to identify those at highest risk for bleeding. Varices were classified endoscopically as suggested by the Japanese Research Society for Portal Hypertension. Patients were followed for 1 to 38 months (median, 23), during which 85 patients (26.5 percent) bled. Multiple regression analysis (Cox’s model) revealed that the risk of bleeding was significantly related to the patient’s modified Child class (an index ofliver dysfunction based on serum albumin concentration, bilirubin level, prothrombin time, and the presence ofascites and encephalopathy), the size ofthe varices, and the presence ofred wale markings (longitudinal dilated venules resembling whip marks) on the varices. A prognostic index based on these variables was devised that enabled us to identify a subset of patients with a one-year incidence of bleeding exceeding 65 percent. The index was prospectively validated on an independent sample of 75 patients with varices and no history of bleeding. We conclude that our prognostic index, which identifies groups ofpatients with oneyear probabilities of bleeding ranging from 6 to 76 percent, can be used to identify candidates for prophylactic treatment. (N Engl J Med 1988; 319;983-9)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom